Month: August 2026

2026.08.23
Miron Tokarski will be speaking at the upcoming webinar, “Meeting the Challenges and Unlocking the Potential of Point-of-Care Molecular Diagnostics”

2026.07.02
Another patent granted. Another step in building global protection for Genomtec’s molecular diagnostics technology

2026.06.03
Genomtec Secures Over EUR 9 Million to Advance Commercialization Strategy and AI-Powered Diagnostics Development

2026.05.19
Launch of the public offering of Genomtec shares to raise funds for the finalization of the M&A process and the commercialization of Genomtec ID and OncoSNAAT® technologies

2026.03.19
Genomtec plans to issue shares. The proceeds will be used to support the M&A process and commercialize projects. The company has concluded an investment agreement with a key shareholder.

Archive

2026.08.23

Miron Tokarski will be speaking at the upcoming webinar, “Meeting the Challenges and Unlocking the Potential of Point-of-Care Molecular Diagnostics”

Miron Tokarski, CEO and Co-Founder of Genomtec S.A., has been invited to serve as a panelist in the upcoming GenomeWeb webinar, “Meeting the ...
Read

Archive